Experimental drug may work against hepatitis C
(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.
Diseases, Conditions, Syndromes
Mar 27, 2013 |
5 / 5 (3) |
1
|
Better long-term outcomes with low hep C viral load
(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, ...
Diseases, Conditions, Syndromes
Mar 25, 2013 |
not rated yet |
0
French patients keep HIV at bay despite stopping drugs (Update)
A small French study of 14 HIV patients who have remained healthy for years after stopping drug treatment offers fresh evidence that early medical intervention may lead to a "functional cure" for AIDS, researchers said Thursday.
HIV & AIDS
Mar 14, 2013 |
not rated yet |
0
No increase in risk of death for patients with well-controlled HIV, reports AIDS journal
For HIV-infected patients whose disease is well-controlled by modern treatment, the risk of death is not significantly higher than in the general population, according to a study published in AIDS, official journal of the Intern ...
HIV & AIDS
Mar 11, 2013 |
not rated yet |
0
'Significant' proportion of HIV positive patients may not be telling NHS staff about their infection
A significant proportion of HIV positive patients may not be disclosing their infection to NHS staff, when turning up for treatment at sexual health clinics, suggests preliminary research published online in the journal Sexually Tr ...
HIV & AIDS
Feb 13, 2013 |
not rated yet |
0
Patients can emit small, influenza-containing particles into the air during routine care
A new study suggests that patients with influenza can emit small virus-containing particles into the surrounding air during routine patient care, potentially exposing health care providers to influenza. Published in The Journal of ...
Diseases, Conditions, Syndromes
Jan 31, 2013 |
not rated yet |
0
Certain mutations give HIV infection an advantage that sticks
(Medical Xpress)—Varieties of HIV that replicate more quickly can cause infected individuals' immune systems to decline faster, new research demonstrates. The results were published by the journal PLOS Pathogens.
HIV & AIDS
Dec 06, 2012 |
5 / 5 (1) |
0
|
Surprise HIV diagnosis becomes life-changing moment
(HealthDay)—It was 1995, and 36-year-old Maria Davis had it all: a successful career as a music promoter and a model, two kids, and a man she loved so much she was going to move thousands of miles to be ...
HIV & AIDS
Nov 30, 2012 |
5 / 5 (2) |
0
Adherence to HIV treatment significantly increases survival, researchers find
(Medical Xpress)—HIV-positive individuals who strictly adhere to highly active antiretroviral therapy (HAART) have a significantly lower probability of premature morbidity and mortality as compared to those with suboptimal ...
HIV & AIDS
Nov 21, 2012 |
not rated yet |
0
|
High fever and evidence of a virus? Caution, it still may be Kawasaki disease
Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide ...
Diseases, Conditions, Syndromes
Nov 05, 2012 |
5 / 5 (1) |
0
|
Non-infected babies born to HIV mothers have reduced immunity to measles
Non-infected babies born to HIV positive mothers should be vaccinated early against measles, to avoid them acquiring the virus or passing it on to others.
HIV & AIDS
Oct 18, 2012 |
not rated yet |
0
No benefit from high-dose multivitamins seen for HIV patients receiving antiretroviral therapy
A new study by Harvard School of Public Health (HSPH) researchers suggests that, for HIV patients receiving highly active antiretroviral therapy (HAART) to treat HIV, there is no benefit from high- vs. standard-dose micronutrient ...
HIV & AIDS
Oct 16, 2012 |
5 / 5 (1) |
0
|
Canada high court lowers bar for HIV disclosure
Canada's Supreme Court on Friday decriminalized the non-disclosure of HIV status prior to sex where no realistic possibility of transmitting the potentially deadly virus exists.
HIV & AIDS
Oct 05, 2012 |
not rated yet |
1
Telaprevir: Added benefit in certain patients with hepatitis C
The drug telaprevir (trade name: Incivo) has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. In an early benefit assessment pursuant to the "Act on the Reform of the Market for ...
Diseases, Conditions, Syndromes
Sep 05, 2012 |
not rated yet |
0
HIV treatment use increases in the US
Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious ...
HIV & AIDS
Sep 03, 2012 |
not rated yet |
0
